Sidley Austin represented Biolojic Design, Ltd. in the deal. Biolojic Design, Ltd. (Biolojic), a biotechnology company, announced it has entered into a multi-target drug discovery collaboration...
Biolojic Design’s Collaboration with Merck KGaA, Darmstadt, Germany
Atia Vision’s Series E Financing
Sidley represented Atia Vision Inc. on the deal. Atia Vision Inc. announced its Series E financing led by Cormorant Asset Management with participation by The Capital Partnership,...
Crown Bioscience’s Acquisition of Indivumed’s CRO Services Business
Freshfields Bruckhaus Deringer advised Indivumed GmbH on the deal while Sidley is represented Crown Bioscience. Indivumed GmbH sold its “IndivuServ” business unit to a wholly owned...
Wella Company’s Acquisition of Briogeo
Simpson Thacher represented Wella Company on the deal while Sidley advised Briogeo. Wella Company announced its definitive agreement to acquire Briogeo, one of the fastest growing...
KKR’s Investment in Biosynth Carbosynth
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....